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Association between metabolic 
syndrome and periodontitis: a 
systematic review and meta-analysis
Abstract: The aim of the present study was to evaluate the association 
between metabolic syndrome (MS) and periodontitis (PD), through a 
systematic review and meta-analysis. Original observational studies 
assessing the association between MS and PD in adults, published 
before May 11th (2017), were identified through electronic searches of 
MEDLINE, EMBASE and Cochrane Library databases. The PRISMA 
(Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 
guideline was used. For studies to be included, they had to mention 
the criteria used to diagnose MS and to have used at least one clinical 
measure to diagnose PD. There was no language restriction. Three 
reviewers independently identified eligible studies for possible inclusion 
in the systematic review and meta-analysis. The quality of the studies 
was evaluated by the Newcastle-Ottawa scale for observational studies. 
A random model meta-analysis was conducted. The strategies used to 
investigate heterogeneity were sequential analysis, subgroup analysis, 
univariate meta-regression and sensitivity analysis. Thirty-three 
studies met the inclusion criteria for the systematic review, and 26 had 
enough information to be included in the meta-analysis, totaling 52,504 
patients. MS and PD were associated with an odds ratio of 1.38 (95%CI 
1.26–1.51; I2 = 92.7%; p < 0.001). Subgroup analysis showed that complete 
periodontal examination (I2 = 70.6%; p < 0.001) partially explained the 
variability between studies. The present findings suggest an association 
between MS and PD. Individuals with MS are 38% more likely to present 
PD than individuals without this condition. Prospective studies should 
be conducted to establish cause and effect relations between MS and PD.
Keywords: Metabolic Syndrome; Periodontal Diseases; Periodontal 
Attachment Loss; Insulin Resistance; Review Literature as Topic. 
Introduction
Periodontitis (PD) is a bacteria-induced chronic inflammatory disease, 
which destroys the bone and connective tissue that support the teeth. It is 
estimated that approximately 20 to 60% of the world’s population may 
have some degree of destructive periodontal disease,1,2,3,4 and that 7.4%, 
representing 538 million individuals, have more severe forms.5 The condition 
is generally diagnosed by a clinical dental examination, since such signs 
and symptoms as dental mobility, halitosis, altered tooth positioning and 
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frequent abscesses tend to be noticed by patients only 
in the final stages of the disease. Patients presenting 
moderate and severe PD have been found to produce 
higher systemic levels of inflammatory and immune 
markers, such as C-reactive protein, interleukin-6, 
interleukin 1β and tumoral necrosis factor (TNF).6,7 
PD treatment is able to reduce these markers.8
The low-grade inflammatory status induced 
by untreated PD creates a systemic inflammatory 
phenotype that has been associated with several 
other systemic diseases/disorders, including 
cardiovascular diseases,9 obesity,10 insulin resistance11 
and metabolic syndrome (MS).12,13,14,15,16 MS consists 
of a group of metabolic abnormalities associated 
with the greater likelihood of developing type 2 
diabetes and cardiovascular disease.17 According 
to the most recent guidelines issued in 2009 by the 
International Diabetes Federation (IDF) and the 
American Heart Association/ National Heart, Lung 
and Blood Institute (AHA/NHLBI), MS is defined as 
the combination of the following conditions: increased 
plasma glucose, hypertension, hypertriglyceridemia, 
low HDL cholesterol and/or elevated abdominal 
circumference.18 Patients must have at least three 
of these abnormalities to be diagnosed with MS. Its 
prevalence varies according to the population studied 
and the criteria used for diagnosis; however, it is 
estimated that a quarter of the world population has 
MS. The risk of developing this condition is thought 
to increase proportionally with age.19
The association between MS and PD has become an 
important topic of research in the scientific literature. 
The presence of continuous low-grade inflammatory 
status could lead to the development of insulin resistance 
and upset the balance of interactions between cytokines 
and the periodontium.17,19 PD may also influence one’s 
general health status by affecting the host’s susceptibility 
to systemic diseases resulting from the accumulation of 
gram-negative bacteria and inflammatory mediators in 
the bloodstream, both of which lead to inflammation.11 
These features also characterize MS.17,19,20
The results of the studies that evaluated the relation 
between PD and MS are widely discrepant.12,13,14,15,16,21,22,23 
Considering that this relationship is characterized 
differently by conflicting findings, there is still 
no consensus on the magnitude of the association 
between MS and PD. Since systematic reviews are 
important tools to reconcile these seemingly divergent 
findings, the aim of the present study was to assess the 
association between MS and PD through a systematic 
review and meta-analysis of observational studies.
Methodology
Focused question
Is there an association between metabolic syndrome 
and periodontal disease demonstrated in observational 
studies? The PECO strategy for the research question 
was: in patients diagnosed with periodontal disease 
and/or metabolic syndrome, the exposure was the 
presence of PD and/or MS, compared with patients 
with no PD and/or no MS. The outcome was any 
measure of prevalence of PD and MS. 
Search strategy
The authors undertook a systematic review to locate 
original studies on the association between PD and 
MS. The study protocol was approved by the Research 
Committee of UFRGS (Study 22842). Observational 
studies were identified, focusing on participants 
diagnosed with PD and MS. The outcome was PD and/
or MS, since cross-sectional studies have no temporal 
component, and do not allow both directions of the 
association to be investigated.  The present systematic 
review was conducted based on guidelines established 
for meta-analyses of observational studies 24 and is 
presented according to the PRISMA Statement.
Electronic databases were systematically searched for 
scientific articles published before May 11th, 2017, which 
evaluated the association between MS and PD. The search 
was conducted in MEDLINE (accessed via PubMed), 
EMBASE and the Cochrane Library, and used the following 
keywords and MeSH terms (*): periodontal attachment 
loss* OR periodontics* OR gingivitis* OR periodontal 
diseases* OR gingival bleeding OR periodontitis* AND 
metabolic syndrome x* OR metabolic syndrome OR 
syndrome x OR plurimetabolic. There was no language 
restriction. Articles in Chinese, Polish and Persian were 
translated with online translation software.   
Relevant unpublished studies were located by 
reviewing abstracts in the annals of main scientific 
events in the field since 2006. The proceedings of 
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the following conferences were searched: EuroPerio, 
promoted by the European Federation of Periodontology; 
IADR General Session, promoted by the International 
Association for Dental Research; AAP Annual Meeting, 
promoted by the American Academy of Periodontology; 
AHA Scientific Sessions, promoted by the American 
Heart Association; the ADA Scientific Session, promoted 
by the American Diabetes Association; and the EASD 
Annual Meeting, promoted by the European Association 
for the Study of Diabetes.  The reference lists of the 
studies included in the review were also searched.
Two reviewers (MLM and MM) independently 
identified eligible studies for possible inclusion in the 
systematic review and meta-analysis, based on their titles 
and abstracts. The articles whose abstracts were selected 
were retrieved for full text evaluation. The studies selected 
for detailed analysis by these two investigators (MLM 
and MM) had a kappa agreement of 0.95. Disagreements 
were settled by a third investigator (RVO).
Studies were considered eligible when meeting 
the following criteria: original epidemiological study, 
observational, cross-sectional, case-control, or cohort 
design, adult sample, use of at least one clinical 
diagnostic criterion for PD that was clearly defined to 
warrant reproducibility, and clearly defined criteria 
for the diagnosis of MS. The studies excluded from 
the analysis, and the reasons for their exclusion, are 
reported in Figure 1.
Data extraction
The data were extracted independently by 
two investigators (MLM and PW), and included 
the participants’ age, gender and smoking status, 
nature of the experimental design, the diagnostic 
criteria used for PD and MS, total number of 
participants, number of participants with PD and 
MS, and study outcomes. 
Quality assessment
The quality of the studies was evaluated using the 
Newcastle-Ottawa scale25 for observational studies. 
The scale assigns a score of zero to nine stars to each 
article, whereby a greater number of stars indicate a 
higher quality study.
290 studies identified from initial search
MEDLINE and EMBASE 
237 studies excluded based
on title and abstract
20 studies excluded 
• Inappropriate design (n=2)
• Lacked data on metabolic syndrome
or periodontal disease (n=8)
• Periodontal disease/metabolic syndrome
diagnosis unclear/not reported/absence of
clinical criteria for periodontal disease (n=8)
• Duplicate of included study (n=2)
53 potentially relevant publicantions retrieved
for full text assessment
33 studies included in systematic review 
26 studies included in metanalisis
7 studies excluded 
• Lacked data on prevalence of metabolic syndrome
or periodontal disease (n=7)
Figure 1. Flowchart of the search for studies, their selection and inclusion.
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Statistical analysis
The general effect size was calculated using the 
reported PD and MS prevalence rates. Baseline values 
were used for cohort and case-control studies. When 
these data were not available, the authors were contacted 
by email. Random effect models were used in the 
analyses to account for between-study variability. 
Four strategies were used to investigate heterogeneity, 
considered high whenever I2 was greater than 50%.26 
The first strategy involved univariate meta-regression, 
performed to assess the effect of age, gender and 
smoking status on estimates of heterogeneity. The 
second step involved successive removal of each study, 
so that its impact on I2 values could be observed. In the 
third step, a subgroup analysis took into account the 
periodontal examination and the MS diagnosis criteria. 
The fourth and last step of the heterogeneity analysis 
involved the sensitivity analyses, which included only 
those studies that received scores of eight or nine stars 
on the Newcastle-Ottawa scale.27 The possibility of 
publication bias was evaluated using a funnel plot of 
the effect size plotted against the standard error of each 
trial. Begg’s and Egger’s tests were used to evaluate 
funnel plot asymmetry, with significant publication 
bias defined as a p-value < 0.1. The analyses were 
performed using STATA software (version 12; Stata 
Corp, College Station, USA). 
Results
The electronic search retrieved 290 articles from 
PubMed and EMBASE. No additional articles were 
found in the Cochrane Library or in any other database 
searched.  Two hundred and thirty-seven studies 
were excluded based on titles and abstracts, resulting 
in 53 articles for full-text evaluation. A total of 33 
studies met the eligibility criteria (29 cross-sectional, 
two case-control and two cohort studies, totalizing 
52,504 participants; Figure 1) and were included in 
the systematic review, and 26 were included in the 
meta-analysis. Seven studies were not included in 
the meta-analysis, because there was no prevalence 
data for PD and/or MS.28,29,30,31,32,33,34 
Table 1 describes the studies included in the review. 
The articles were published between 2007 and 2017, 
and most were conducted in Asian countries. PD was 
diagnosed by a complete periodontal examination 
in seventeen studies,12,23,28,31,32,33,35,36,37,38,39,40,41,42,43,44,45 
and by a part ia l  per iodontal examinat ion 
in sixteen studies.13,14,15,16,22,29,30,34,46,47,48,49,50,51,52,53 
Concerning the definition criteria for PD, eleven 
studies12,14,15,22,29,30,34,49,50,51,52 used the Community 
Periodontal Index (CPI),54 and seven studies23,37,40,42,43,45,47 
used the classification system proposed by Page and 
Eke.55 The remaining fifteen studies established other 
diagnostic criteria for PD.13,16,28,31,32,33,35,36,38,39,41,44,46,48,49 
Thirteen studies diagnosed MS using the National 
Cholesterol Education Program - Adult Treatment 
Panel III (NCEP ATP III) criteria,12,13,15,16,22,23,28,32,33,37,46,49,51 
ten used the 2005 IDF criteria,29,30,35,38,39,40,41,42,47,48 four 
used both the  IDF 2009 and AHA/NHBLI 2009 
criteria,14,36,50,52 three used the IDF 2009 criteria 44,45,53 
and three studies used other classification criteria.31,34,43 
Table 2 shows the quality assessment of the included 
studies. Fifteen studies scored seven or more stars, 
indicating that 45.5% of the studies had very good 
quality. All the studies controlled the confounding 
variables. The most commonly controlled factors 
were age, gender and smoking habits. No article 
presented poor quality according to the Newcastle-
Ottawa scale. 
The estimated PD prevalence ranged from 5.77% 
to 92.89%, whereas the MS prevalence ranged from 
5.22% to 83.21%. The meta-analysis revealed a positive 
association between MS and PD, with an odds ratio 
(OR) of 1.38 (95%CI 1.26–1.51; I2 = 92.7%; p heterogeneity 
< 0.001) (Figure 2).  Meta-regression showed that age 
explained 22% of the heterogeneity of the results 
(p = 0.01), whereas gender (p = 0.09) and smoking 
status (p = 0.40) failed to explain heterogeneity. In 
addition, none of the studies in itself could explain 
the heterogeneity when rerunning the meta-analysis 
by excluding one study at a time. Subgroup analyses 
were conducted by dividing the studies according to 
periodontal examination (complete or partial) or by the 
criteria used to define MS. When PD was diagnosed 
by a complete dentition examination, an OR of 1.16 
(95%CI 1.08 –1.25; I2 = 70.6%) was obtained (Figure 3). 
Studies that used a partial periodontal examination 
showed an OR of 1.58 (95%CI 1.38–1.82; I2 = 90.8%).  The 
magnitude of association between the two conditions, 
according to the MS criteria used, was 1.38 (95%CI 
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1.19–1.61; I2 = 91.3%) for NCEP ATP III, 1.28 (95%CI 1.07–
1.53; I2 = 85.9%) for IDF 2005, and 1.49 (95%CI 1.22–1.82; 
I2 = 93.7%) for the IDF 2009 criteria (Figure 4). The authors 
also evaluated if study quality could be responsible 
for the heterogeneity observed. The evaluation of six 
studies with higher scores in the Newcastle-Ottawa 
quality assessment scale16,23,37,41,42,47 did not decrease 
the heterogeneity (I2 = 81.4 %; p < 0.001). 
There was evidence of publication bias, as 
demonstrated by the funnel plot, Egger’s regression 
test (p = 0.03) and Begg’s test (p =0.005; Figure 5). 
Discussion
The present findings suggest that individuals with 
MS are 38% more likely to have PD than individuals 
without this condition. This meta-analysis was 
associated with significant heterogeneity, which 
may be attributed to variability across the studies, 
in regard to PD diagnosis (complete vs. partial 
dental examination). Our results corroborate those 
of the single meta-analysis, which also assessed 
the association between MS and PD, and which 
reported an OR of 1.90 (95%CI 1.54–2.34).21 The 
main limitation of this meta-analysis was the 
inclusion of studies with PD diagnosed by both 
clinical and radiographic methods. Considering 
that low-grade inflammatory status accounts for the 
biological plausibility of the relationship between 
MS and PD, the clinical examination should be 
preferred in this scenario, since the presence of 
inflammation in periodontal tissues cannot be 
assessed by radiologic methods. Four studies 
included in the previous systematic review21 were 
not included in the present study, because they 
used radiographic methods for PD diagnosis,56,57 or 
lacked information regarding PD or MS diagnosis 
criteria.58,59 The authors considered this limitation 
and performed a subgroup analysis, dividing the 
studies into two categories: those with secure PD 
diagnosis, defined by the presence of severe PD 
defined both clinically and radiographically, and 
those with insecure PD diagnosis, and less severe 
or not well-defined cases in the original study. 
Several studies in the literature have investigated 
the relationship between MS and PD. However, 
Table 2. Newcastle-Ottawa quality assessment scale adapted 
to observational studies.
Study Selection Comparability Outcome
Borges, 2007 * * **
Shimazaki, 2007 ** ** **
D’Aiuto, 2008 **** ** **
Kahder, 2008 *** * **
Kowalski, 2009 ** * *
Kushiyama, 2009 * ** **
Li, 2009 ** * **
Morita, 2009 ** * **
Adriankaja, 2010 *** ** **
Benguigui, 2010 **** ** **
Han, 2010 *** ** **
Morita, 2010 ** ** **
Timonen, 2010 *** * *
Bracho, 2011 ** * *
Chen, 2011 ** ** *
Li, 2011 ** * *
Kwon, 2011 ** ** **
Fukui, 2012 *** ** ***
Yu, 2012 ** ** **
Sora, 2013 *** ** ***
Furuta, 2013 **** * **
Thanakun, 2014 ** * *
La Monte, 2014 **** ** **
Alhabashneh, 2015 *** ** ***
Gomes-Filho, 2015 *** ** ***
Kim, 2015 *** * **
Minagawa, 2015 *** ** **
Safavi, 2015 *** * **
Chen, 2016 *** * **
Jaramillo, 2016 *** ** **
Kaye, 2016 *** ** **
Musskopf, 2016 *** ** **
Kikui, 2017 *** ** **
Scale ranges between zero and nine stars. Highest quality studies 
awarded maximum of four stars for selection, three stars for 
outcome and two stars for comparability.
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Study ID RR (95% CI) % Weight
Borges, 200721 1.07(0.78, 1.47) 3.27
Shimazaki, 200745 2.69 (1.42, 5.09) 1.53
D’Aiuto, 200846 1.12 (1.03, 1.22) 5.02
Kowalski, 200947 3.60 (2.22, 5.84) 2.19
Kushiyama, 200911 1.58 (1.24, 2.02) 3.86
Li, 200934 1.15 (0.92, 1.43) 4.07
Andriankaja, 201012 1.49 (1.21, 1.83) 4.18
Benguigui,201022 1.16 (1.03, 1.31) 4.83
Han, 201013 1.88 (1.60, 2.21) 4.53
Bracho, 201149 1.36 (0.89, 2.09) 2.53
Chen, 201148 1.39 (1.11, 1.74) 4.01
Kwon, 201114 1.59 (1.51, 1.67) 5.16
Li, 201138 1.43 (0.92, 2.21) 2.46
Fukui, 201215 1.35 (1.21, 1.49) 4.93
Yu, 201239 1.06 (1.00, 1.12) 5.14
LaMonte, 201436 0.97(0.88, 1.07) 4.96
Thanakun, 201435 1.27 (0.98, 1.65) 3.72
Alhabashneh, 201540 3.00 (1.49, 6.02) 1.34
Gomes-Filho, 201541 0.91 (0.69, 1.19) 3.63
Minagawa, 201537 1.19(1.04, 1.35) 4.76
Safavi, 201550 1.74 (1.44, 2.10) 4.31
Chen, 201652 5.44(3.28, 9.04) 2.07
Jaramillo, 201642 1.21 (1.01, 1.45) 4.39
Kaye, 201643 1.15 (1.10, 1.19) 5.20
Musskopf, 201644 1.62 (1.13, 2.34) 2.93
Kikui, 201751 1.17(1.07, 1.28) 5.00
Overall (I-squared = 92.7%, p = 0.000) 1.38 (1.26, 1.51) 100.00
NOTE: Weights are from random effects analysis
.111 1 9.04
Figure 2. Meta-analyses of the association between periodontal diseases and metabolic syndrome.
the results of these studies have been widely 
discrepant. Whereas a number of them have 
reported positive associations between these two 
conditions,12,13,14,15,16,21 other investigations have 
found no relationship between them22,23. Reasons 
for the variability in results include differences in 
diagnostic criteria for PD and MS, the involvement 
of untrained examiners in diagnosing PD, the 
improper control of confounding factors and the 
presence of selection bias. 
Our meta-analysis showed significant heterogeneity, 
which was explored by several methods. A decrease 
in heterogeneity was observed when only studies 
using complete dental examination were considered 
(I² for all studies: 92.7% and for complete dental 
examination: 70.6%), indicating that studies using 
complete periodontal examination presented more 
reliable estimates. The higher variability found 
in studies using partial dental examination (I² = 
90.8%) may be attributed to erroneous diagnosis of 
these individuals. The extension and severity of PD 
should be assessed by a full six-site examination, 
considered the gold standard for PD.60 Half of the studies 
conducted partial examinations, which are known 
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Study ID RR (95% CI) % Weight
Partial periodontal examination
Borges, 200721 1.07 (0.78, 1.47) 3.27
Shimazaki, 200745 2.69(1.42, 5.09) 1.53
D'Aiuto, 200846 1.12 (1.03, 1.22) 5.02
Kowalski, 200947 3.60 (2.22, 5.84) 2.19
Andriankaja, 201012 1.49 (1.21, 1.83) 4.18
Han, 201013 1.88 (1.60, 2.21) 4.53
Bracho, 201149 1.36 (0.89, 2.09) 2.53
Chen, 201148 1.39 (1.11, 1.74) 4.01
Kwon, 201114 1.59 (1.51, 1.67) 5.16
Fukui,201215 1.35 (1.21, 1.49) 4.93
Safavi, 201550 1.74 (1.44, 2.10) 4.31
Chen, 201652 5.44 (3.28, 9.04) 2.07
Kikui, 201751 1.17 (1.07, 1.28) 5.00
Subtotal (I-squared = 90.8%, p = 0.000) 1.58(1.38, 1.82) 48.72
Complete periodontal examination
Kushiyama, 200911 1.58 (1.24, 2.02) 3.86
Li, 200934 1.15 (0.92, 1.43) 4.07
Benguigui, 201022 1.16 (1.03, 1.31) 4.83
Li,201138 1.43(0.92, 2.21) 2.46
Yu, 201239 1.06 (1.00, 1.12) 5.14
LaMonte, 201436 0.97 (0.88, 1.07) 4.96
Thanakun, 201435 1.27 (0.98, 1.65) 3.72
Alhabashneh, 201540 3.00 (1.49, 6.02) 1.34
Gomes-Filho, 201541 0.91(0.69, 1.19) 3.63
Minagawa, 201537 1.19 (1.04, 1.35) 4.76
Jaramillo, 201642 1.21 (1.01,1.45) 4.39
Kaye,201643 1.15 (1.10, 1.19) 5.20
Musskopf, 201644 1.62 (1.13, 2.34) 2.93
Subtotal (I-squared = 70.6%, p = 0.000) 1.16 (1.08, 1.25) 51.28
Overall (I-squared = 92.7%, p = 0.000) 1.38 (1.26, 1.51) 100.00
NOTE: Weights are from random effects analysis
.111 1 9.04
Figure 3. Subgroup analyses with complete and partial periodontal examination.
to underestimate the prevalence of PD.60 In addition 
to variability in the examination protocol used to 
diagnose PD, the criteria used to detect this condition 
differed across the studies. Eleven studies used CPI 
criteria to diagnose the disorder. The Community 
Periodontal Index of Treatment Needs (CPITN)54 was 
initially developed to assess the treatment needs of 
patients with PD, and requires ten teeth to be checked 
for gingival bleeding, supra- and subgingival calculus 
and periodontal pockets (classified according to size, 
namely those measuring between 4 and 5 mm and those 
measuring 6mm or more). WHO recommendations were 
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Study ID RR (95% CI) % Weight
NCEP-ATP III
Borges, 200721 1.07 (0.78, 1.47) 3.27
Shimazaki, 200745 2.69 (1.42, 5.09) 1.53
Kushiyama, 200911 1.58 (1.24, 2.02) 3.86
Andriankaja, 201012 1.49 (1.21, 1.83) 4.18
Benguigui, 201022 1.16 (1.03, 1.31) 4.83
Chen, 201148 1.39 (1.11, 1.74) 4.01
Kwon, 201114 1.59 (1.51, 1.67) 5.16
Fukui, 201215 1.35 (1.21, 1.49) 4.93
LaMonte, 201436 0.97 (0.88, 1.07) 4.96
Safavi, 201550 1.74 (1.44, 2.10) 4.31
Subtotal  (I-squared = 91.3%, p = 0.000) 1.38 (1.19, 1.61) 41.04
2.07
IDF 2005 5.00
D'Aiuto, 200846 1.12 (1.03, 1.22) 5.02
Kowalski, 200947 3.60(2.22, 5.84) 2.19
Li, 200934 1.15 (0.92, 1.43) 4.07
Li, 201138 1.43(0.92, 2.21) 2.46
Yu, 201239 1.06(1.00, 1.12) 5.14
Alhabashneh, 201540 3.00 (1.49, 6.02) 1.34
Gomes-Filho, 201541 0.91 (0.69, 1.19) 3.63
Subtotal (I-squared = 85.9%, p = 0.000) 1.28(1.07, 1.53) 23.85
4.96
IDF 2009 1.88 (1.60, 2.21) 4.53
Han, 201013 1.36(0.89, 2.09) 2.53
Bracho, 201149 1.27 (0.98, 1.65) 3.72
Thanakun, 201435 1.19(1.04, 1.35) 4.76
Minagawa, 201537 5.44 (3.28, 9.04) 2.07
Chen, 201652 1.15 (1.10, 1.19) 5.20
Kaye, 201643 1.62 (1.13, 2.34) 2.93
Musskopf, 201644 1.17 (1.07,1.28) 5.00
Kikui, 201751 1.49 (1.22,1.82) 30.72
Subtotal (I-squared = 93.7%, p = 0.000) 100.00
AACE 2003
Jaramillo, 201642 1.21 (1.01, 1.45) 4.39
Subtotal (I-squared = .%, p = .) 1.21 (1.01, 1.45) 4.39
Overall (I-squared = 92.7%, p = 0.000) 1.38 (1.26, 1.51) 100.00
NOTE: Weights are from random effects analysis
.111 1 9.04
Figure 4. Subgroup analyses with criteria used for metabolic syndrome diagnosis.
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later amended to include the required measurement of 
periodontal attachment loss, leading to the renaming 
of the diagnostic index as CPI (Community Periodontal 
Index). Although the CPI was not initially designed 
for use in epidemiological studies, it is widely used in 
this type of research, although it has proved deficient 
in assessing the periodontal conditions of several 
populations reliably.61 This low reliability may be 
attributed to its nature as a partial exam, and of 
investigating symptoms in a hierarchical sequence.
It is reasonable to think that different MS diagnostic 
criteria could account for the variability in the studies. 
For example, although the NCEP ATP III criteria are 
used by a number of studies, they do not account for 
population differences in body composition when 
defining abdominal circumference cut points. The 
existence of documented differences between the body 
composition of individuals of different ethnicities62 
requires population-specific visceral fat cut-offs to be 
established, as suggested by the IDF and AHA/NHBLI 
in 2005.63 In fact, the 2009 guidelines set in consensus 
by these institutions established population-specific 
abdominal circumference cut points.18,19 NCEP ATP 
III criteria may underestimate the prevalence of MS in 
some populations, as has been found in some studies 
of Asian individuals12,15,16,49 for whom specific cut points 
were later recommended.63,64 However, the variability 
among studies was not explained by the different MS 
diagnostic criteria used in the present study. 
In addition to investigating the association 
between PD and MS, some authors also studied 
the association between PD and specific features 
of MS. When analyzing the factors separately, the 
results ranged from the absence of an association to 
an adjusted OR up to 1.8 (95%CI 1.2–2.8) for elevated 
abdominal circumference,46 2.20 (95%CI 1.40- 3.60) 
for low HDL cholesterol,46 1.59 (95%CI 1.20–2.11) for 
hypertension,12 2.20 (95%CI 1.3–3.9) for alterations in 
glucose homeostasis,46 and a raw OR of 1.38 (95%CI 
1.17–1.62) for hypertriglyceridemia.15 Since these results 
are similar to those found for MS by these and other 
authors,21 the discussion regarding the relevance of 
the syndrome persists. The issue of whether MS is 
more than a combination of its individual components 
remains controversial.65 Nevertheless, treatment for 
one of these individual conditions could have an effect 
on the other, thus enhancing the treatment benefits 
and optimizing the effects of the intervention on the 
patient’s health.
The nature of the present review, with the inclusion 
of mainly cross-sectional studies, may be considered 
a limitation of this meta-analysis, since no cause 
and effect relations could be established between 
the two conditions. It should also be acknowledged 
that unpublished studies and individual studies with 
quality limitations may still be relevant, despite the 
best efforts to conduct a broad search, and despite 
the lack of statistical evidence of bias. 
Conclusion
In conclusion, considering its limitations, this 
systematic review with meta-analysis suggests an 
association between MS and PD. Further research in 
this field could include prospective studies conducted 
to establish cause and effect relations between these 
two conditions, and whether specific treatments 
could influence the development of both conditions.
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